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Renal replacement therapy in Latin America. The Latin Amer- SLANH RENAL REPLACEMENT THERAPY
ican Society of Nephrology and Hypertension (SLANH) Dial- REGISTRY ACTIVITY
ysis and Renal Transplantation Registry was created in Octo-
The SLANH Dialysis and Renal Transplantation Reg-ber 1991 as a multinational, mainly voluntary registry. Annual
istry was created in October 1991, and it is operateddata reports on the incidence, prevalence and outcome of renal
by a Coordinating Committee located in Montevideo,replacement therapy (RRT) in the region have been issued.
The RRT prevalence increased from 123 per million population Uruguay. The primary objectives, general organization,
(pmp) in 1992 to 180 pmp in 1997, and the acceptance rate and financing of the Registry were stated during the first
was 57 pmp in 1997. Among incident patients, 32.8% were meeting of National Representatives held in Montevideo
older than 65 years and 24% had diabetic nephropathy. Mortal- in 1994 [3]. Definitions, data collection, and statistical
ity rate in dialysis patients was 152 deaths per 1000 patient- methodology applied have been previously publishedyears at risk. The low acceptance rate is mainly a consequence
[3, 4]. At the request of the Coordinating Committee,of economic and health care system difficulties in Latin Ameri-
the National Registry of each local society of nephrologycan countries. A large number of patients in this region do
provides data to the primary database. Most of thesenot reach RRT due to restricted availability and difficulties
in referral. There are important demographic, socioeconomic, national registries are voluntary.
acceptance availabilities, and questionnaire response rate het- Data are collected in three types of questionnaires:
erogeneity among Latin American countries. Because of this patient, center and country questionnaire. The country
heterogeneity, it is very difficult to compare data obtained from questionnaire includes renal replacement therapy (RRT)
different countries of this region of the world. To overcome
modality, incidence and prevalence rates. This databasethis difficulty is the critical challenge for the future activity of
is updated every year.the SLANH Registry.
The yearly evolution of the incidence and prevalence
rates of the registered end-stage renal disease (ESRD)
dialysis patients is presented in Figure 1. The number
Latin America is a heterogeneous region with very of registered patients increased during the first few years
important differences in social and economic status. The of the registry activity. Afterwards it decreased abruptly,
gross national product (GNP) ranges from $900 per cap- and now it seems to be growing gradually.
ita per year in Haiti to $26,000 in Puerto Rico, and the Since the creation of the registry, annual data reports
Human Development Index from 0.340 to 0.893 [1]. The on the incidence, prevalence and outcome of RRT in
Latin American Society of Nephrology and Hyperten- the region have been issued [3–10]. The time course of
sion (SLANH) comprises 21 countries with a total popu- RRT prevalence from 1992 to 1997 showed a gradual
lation of 491 million inhabitants (Table 1) [2]. increase (Fig. 2).
While the overall response rate to the dialysis patient
questionnaire was 22% in 1997 (Fig. 3), five countries
(Chile, Panama, Puerto Rico, Dominican Republic and1Reporting members and countries: Ana Marı´a Cusumano and Ce´sar
Agost-Carren˜o (Argentina); Herland Vaca Diez (Bolivia); Miguel Uruguay) sent 100% of their patient data.
Riella (Brasil); Hugo Poblete and Susana Elgueta (Chile); Gonzalo
Mejı´a (Colombia); Manuel Cerdas-Caldero´n (Costa Rica); Miguel Al- 1997 RRT prevalence and incidencemaguer Lo´pez (Cuba); Ricardo Leiva-Merino (El Salvador); Plutarco
Castellanos (Honduras); Guillermo Garcı´a-Garcı´a (Me´xico); Elı´as According to the country questionnaires there were
Pe´rez Guardia; (Panama´); Silvio Franco (Paraguay); Wilfredo Cortez 88,437 patients on RRT in Latin America, or 180 per mil-(Peru´); Eduardo Santiago Delpı´n (Puerto Rico); Guillermo A´lvarez
lion population (pmp). Of these patients, 64% were onand Hilda Lafontaine (Repu´blica Dominicana); Carmen Luisa Milane´s,
Mirna Infante and Marcos Ariza (Venezuela). hemodialysis (HD), 26% were on peritoneal dialysis (PD)
and 10% were living with a transplanted kidney (Table 1). 2000 by the International Society of Nephrology
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Table 1. Prevalence of renal replacement therapy in Latin America
Total Prevalence
population GNP b
millions a (US)c HDI c,d HD PD RT Total pmpb
Argentina 35.41 8489 0.888 12000 700 – 359
Bolivia 7.92 2617 0.593 79 55 23 20.7
Brazil 167.05 5928 0.809 25468 4332 3600 200
Chile 14.69 9930 0.893 5077 158 1300 445
Colombia 36.20 6347 0.850 1600 2000 1200 133
Costa Rica 3.58 5969 0.889 74 30 454 156
Cuba 11.19 3100 0.729 755 145 597 134
Ecuador 11.94 4602 0.767 305 50 – 30
El Salvador 6.03 2610 0.604 105 160 81 57
Guatemala 11.24 3682 0.615 147 125 – 24
Haiti 7.48 917 0.340 – – – –
Honduras 5.98 1977 0.573 76 113 – 32
Mexico 97.24 6769 0.855 1636 13452 – 155
Nicaragua 4.73 1837 0.547 – – – –
Panama 2.72 6258 0.868 202 34 60 109
Paraguay 5.22 3583 0.707 380 0 75 87
Peru 24.69 3940 0.729 1528 29 – 63
Puerto Rico 3.82 26977 2321 684 285 861
R. Dominicana 8.10 3923 0.879 395 – – 52
Uruguay 3.22 6854 0.885 1827 88 239 669
Venezuela 22.78 8090 0.860 3000 500 870 192
Total 491.23 56975 22655 8807 180
a Mid year estimation–1997. Demographic Bulletin–CELADE [2]
b Abbreviations are: HD, hemodialysis; GNP, gross national product; PD, peritoneal dialysis; RT, renal transplant; pmp, per million population
c Human Development Index
d Human Development Report 1998. UN Program for Development [1]
Fig. 1. Registered end-stage renal disease
(ESRD) dialysis patients in Latin America
from 1991 to 1997. Symbols are: (h), inci-
dence; (j), prevalence.
The prevalence of patients on dialysis in 1997 was 162 phropathy (21.1%), glomerulonephritis (18.4%), and di-
abetic nephropathy (16.1%).pmp: 72% were on HD and 28% on PD (Table 1 and Fig.
4). The prevalence of dialysis therapy was very different The overall acceptance rate in Latin America was 57
pmp (20 patients) in 1997, but the acceptance rates forfrom country to country: Puerto Rico had the highest
and Bolivia the lowest prevalence rate. The percentage each country varied widely. Argentina, Puerto Rico, and
Uruguay had an incidence rate over 100 patients pmp,of patients on PD was very high in Mexico, but very low
in Chile. whereas Brazil, Costa Rica, Cuba, Chile, and the Domin-
ican Republic had an incidence rate between 50 and 100The mean age of dialysis patients was 52.5 (6 17.4)
years, and 28.3% of the patients were older than 65 pmp. In other Latin American countries the acceptance
rate was less than 50 pmp. Patients with ESRD fromyears. Fifty-eight percent of the patients were male. The
most frequent types of nephropathy were vascular ne- Ecuador, Guatemala and Mexico were accepted to RRT,
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Fig. 2. Renal replacement therapy prevalence in Latin America, from
1992–1997.
Fig. 3. Percent of ESRD dialysis patients
registered (j) in different Latin American
countries for 1997.
Fig. 4. Dialysis modalities prevalence in
Latin America for 1997. Symbols are: (h),
hemodialysis patients; (j), peritoneal dialysis
patients.
but the incidence rates were not reported. The ESRD nate conclusion is that a substantial number of ESRD
patients die each year without RRT in Latin America.incidence by country is presented in Figure 5.
Epidemiological reasons could partially explain these The mean age of the incident patients averaged 54.4
(617.8) years and 32.8% of the patients were older thandifferences, but these numbers primarily represent eco-
nomic restrictions in the health care system. A large 65 years. Fifty-eight percent of the patients were male.
The leading causes of ESRD were diabetic (24.4%), vas-number of patients in Latin America do not reach RRT
due to restricted acceptance and availability of these cular (19.5%), and glomerular (12.1%) nephropathy.
The proportion of diabetic nephropathy among incidenttherapies, and difficulty in making referrals. The unfortu-
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Fig. 6. Percent of incident ESRD patients with diabetic nephropathyFig. 5. Renal replacement therapy acceptance rate in Latin America
for Latin America, 1997.for 1997.
Table 2. Standardized mortality rate and standardized time of hospitalization rate
Standardized mortality ratea Standardized time of hospitalization
Cause of ESRD (deaths per 1000 patient-years) (days per patient-year)b
Glomerulonephritis 85.3 6.96
Hypertension 152.5 8.18
Diabetes 246.2 10.50
Other 143.1 7.87
Total 139.3 7.83
a Standard: 1991–1994 Latin American Registry Mortality Table
b Standard: 1991–1994 Latin American Registry Hospitalization Time Table
highest incidence in Latin America (Fig. 5), but although
Puerto Rico has the highest percentage of patients with
diabetes in Latin America, Uruguay has the lowest (Fig.
6). Differences in the prevalence of diabetic disease in
the general population and differences in the care of
diabetic patients during the period prior to ESRD could
also explain these rates. During the decade 1987 to 1997,
both the number of transplants per year and the cumula-
tive number of transplanted kidneys gradually increased
(Fig. 7).
Fig. 7. Transplants registered in Latin America from 1992 to 1997. Dialysis morbidity and mortality
Symbols are: (h), performed during the year; (j), cumulative.
The adjusted hospitalization time was 7.83 days/pa-
tient-year (Table 2). The standard was the Latin Ameri-
can 1991 to 1994 hospitalization timetable [9]. Diabetics
had the highest value (10.5 days/patient-year). The mor-patients (Fig. 6) ranged between 16% in Uruguay to 57%
tality rate in dialysis patients was 152 deaths per 1000in Puerto Rico. It has been claimed that this variation in
patient-years at risk. Mortality rates were greater fordiabetic percentage is related to incidence differences.
HD (157 deaths per 1000 patient-years at risk) than PDFor example, countries with a high incidence of ESRD,
patients (108 deaths per 1000 patient-years at risk).such as the United States, Japan, and Puerto Rico, are
Mortality was adjusted by age and kidney disease,the same countries with a high percentage of sicker pa-
using the 1991 to 1994 Latin American dialysis mortalitytients and therefore, a high acceptance rate of those with
table as the standard [9]. Four major categories of ESRDdiabetic nephropathy [11]. This opinion does not seem
etiologies were considered: diabetes, hypertension, glo-to be supported if the incidence of ESRD in Uruguay
merulonephritis, and other disease. Age groups wereand Puerto Rico is compared with the percentage of
incident patients with diabetes. Both countries have the defined using five-year intervals, except the younger-
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than-15-years and older-than-85-years age brackets. The Questionnaire response rate. Only five countries pro-
vided a 100% response for their patients’ questionnaire.adjusted mortality rate was 139 deaths/1000 patients-
years at risk (Table 2). Patients with glomerulonephritis Because of the heterogeneity in the above factors, it
is very difficult to compare data obtained from differenthad the lowest mortality rate (85 per 1000 patient-years)
and the highest mortality was observed in patients with countries of Latin America as well as with other coun-
tries or regions of the world. The critical challenge fordiabetic renal disease.
the future activity of the SLANH Registry is how to
overcome these difficulties.
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